. Platelets modulate ischemia/reperfusion-induced leukocyte recruitment in the mesenteric circulation. Am J Physiol Gastrointest Liver Physiol 281: G1432-G1439, 2001.-P-selectin-dependent leukocyte-endothelial cell adhesion has been implicated in the pathogenesis of ischemia/reperfusion (I/R) injury in several vascular beds, including the gut. Because platelet-endothelial (P/E) cell adhesion also occurs in postischemic venules, the possibility exists that the expression of P-selectin on the surface of platelets that are adherent to venular endothelial cells may mediate the leukocyte recruitment elicited by I/R. P-selectin expression [dual radiolabeled monoclonal antibody (MAb) technique] and neutrophil accumulation [myeloperoxidase (MPO) activity] were measured in the postischemic small intestine of untreated rats and rats treated with either antiplatelet serum (APS) or MAbs directed against either P-selectin, GPIIb/IIIa, or fibrinogen. The increases in P-selectin expression and tissue MPO normally elicited by I/R were significantly attenuated in the different treatment groups, suggesting that I/R-induced neutrophil recruitment is a platelet-dependent, P-selectin-mediated process. Intravital microscopy was then employed to examine this process relative to leukocyte-endothelial cell adhesion in postischemic rat mesenteric venules. The recruitment of adherent and emigrated leukocytes after I/R was attenuated by pretreatment with a MAb against, either P-selectin, GPIIb/ IIIa, or fibrinogen, as well as an Arg-Gly-Asp peptide. Whereas thrombocytopenia greatly blunted leukocyte emigration, it did not alter the leukocyte adherence response to I/R. These findings suggest that platelet-associated P-selectin contributes to the accumulation of leukocytes in postischemic tissue via a mechanism that alters transendothelial leukocyte migration. P-selectin; GPIIb/IIIa; fibrinogen; leukocyte emigration REPERFUSION OF ISCHEMIC TISSUES leads to changes in the microvasculature that are similar to those observed in an inflamed organ. These responses, which are most pronounced in postcapillary venules, include an enhanced production of reactive oxygen species, increased expression of adhesion molecules on endothelial cells and circulating blood cells, leukocyte-and platelet-endothelial (P/E) cell adhesion, and endothelial barrier dysfunction (4). Work from our laboratory and by others suggests that the recruitment of activated and adherent leukocytes (primarily neutrophils) is the rate-determining step in the development of microvascular dysfunction and tissue injury following ischemia/reperfusion (I/R) (4, 21). However, there is a growing body of evidence that also implicates other circulating blood cells, including platelets, as potential modulators of I/R-induced microvascular alterations and tissue injury.
creased expression of adhesion molecules on endothelial cells and circulating blood cells, leukocyte-and platelet-endothelial (P/E) cell adhesion, and endothelial barrier dysfunction (4) . Work from our laboratory and by others suggests that the recruitment of activated and adherent leukocytes (primarily neutrophils) is the rate-determining step in the development of microvascular dysfunction and tissue injury following ischemia/reperfusion (I/R) (4, 21) . However, there is a growing body of evidence that also implicates other circulating blood cells, including platelets, as potential modulators of I/R-induced microvascular alterations and tissue injury.
A role for platelets in the pathogenesis of I/R injury is supported by reports describing a beneficial effect of platelet depletion (10) . Further support is provided by recent studies that demonstrate that intestinal I/R is associated with the recruitment of rolling and adherent platelets in postcapillary venules and that the density (cells per unit vessel area) of recruited platelets can exceed the density of adherent leukocytes by an order of magnitude (23) . Several adhesion molecules (P-selectin and GPIIb/IIIa) and procoagulant factors (e.g., fibrinogen) have been implicated in the P/E cell adhesion that is elicited by I/R (24) . Furthermore, it has been proposed that I/R-induced recruitment of leukocytes may be dependent on the initial adhesion of platelets to venular endothelium (2) . Two lines of evidence support the possibility that I/R-induced leukocyte recruitment is dependent on the expression of P-selectin by platelets that are adherent to venular endothelium: 1) P-selectin expressed on the surface of adherent, activated platelets can sustain leukocyte rolling and adherence in vitro (8, 20, 33) , and 2) Pselectin is a major determinant of I/R-induced leukocyte recruitment in postcapillary venules (18, 26) . However, the quantitative importance of platelets in the recruitment of leukocytes into postischemic tissues and the role of P-selectin in this process remain poorly understood.
The overall objectives of this study were 1) to determine whether platelets contribute to the increased P-selectin expression that is detected in postischemic intestine and 2) to define the contribution of platelets to I/R-induced, P-selectin-dependent leukocyte recruitment. These objectives were met using two experimental approaches. In one series of experiments, intestinal P-selectin expression and tissue myeloperoxidase (MPO) were measured after I/R in control rats and in rats pretreated with different platelet-directed interventions that either eliminate the circulating pool of these blood cells (i.e., produce thrombocytopenia) or that have been shown to interfere with the adhesion of platelets to endothelial cells [e.g., monoclonal antibody (MAb) against GPIIb/IIIa] (23, 24) . In a separate series of experiments, the technique of intravital microscopy was used to monitor leukocyte-endothelial cell adhesion to more precisely define the step in the leukocyte adhesion cascade (adhesion vs. emigration) that accounts for the diminished I/R-induced neutrophil accumulation induced by different platelet-directed interventions. The results of this study implicate platelet-associated P-selectin in the recruitment of leukocytes after I/R.
MATERIALS AND METHODS

Experimental Animals
All experimental procedures were performed on male Sprague-Dawley rats (Harlan Laboratories, Frederick, MD) weighing 175-250 g. The rats were placed on standard laboratory chow and fed ad libidum until 0 h before the experiments. All animals were anesthetized (intraperitoneally) with Inactin (thiobutabarbital) at a dose of 120 mg/kg, and a tracheotomy was performed to facilitate breathing. The experimental procedures described herein were reviewed and approved by the Institutional Animal Care and Use Committee of Louisiana State University Health Sciences Center.
Antibodies and Reagents
The MAbs used for in vivo quantification of P-selectin were RMP1, a murine IgG2 MAb against rat P-selectin (32), and P-23, a nonbinding (irrelevant) murine IgG1 directed against human P-selectin (22) . RMP-1 was also employed as a blocking MAb for immunoneutralization of P-selectin (13) . Both RMP-1 and P-23 were provided by Dr. D. C. Anderson (Pharmacia & UpJohn, Kalamazoo, MI). Two GPIIb/IIIa-blocking MAbs 7E3Ј (Eli Lily, Indianapolis) and an F(abЈ)2 fragment of 7E3Ј (Centocor, Malvern, PA) were used to interfere with P/E cell adhesion. MAb 7E3 has been previously shown to completely inhibit ADP-induced aggregation of rat platelets when administered at a dose of 0.50 mg/kg body wt (11) . 7E3 F(abЈ)2 similarly inhibits the aggregation and adhesion of rat platelets, but its binding affinity to rat GPIIb/IIIa is 7.0 g, which compares with a binding affinity of 67 g for the parent antibody (29) . Also, rabbit anti-human fibrinogen (DAKO, Carpenteria, CA), anti-rat platelet serum (Accurate Chemicals, Westbury, NY), and the RGD peptide GRGDSP (GIBCO, Gaithersburg, MD) were used to interfere with platelet function. These reagents have been previously employed in experimental models of intestinal I/R and shown to interfere with P/E cell adhesion (23, 24) .
Dual Radiolabeled MAb Technqiue
The binding (RMP-1) and nonbinding (P-23) MAbs were labeled with 125 I and 131 I (New England Nuclear, Boston, MA), respectively, using the Iodogen method (9) . In brief, Iodogen (Sigma Chemicals, St Louis, MO) was dissolved in chloroform at a concentration of 0.5 mg/ml, and 250 l of this solution were placed in glass tubes and evaporated under nitrogen. A 250-l sample of MAb was added to each Iodogencoated tube, and either 131 I or 125 I, with a total activity of 250 Ci, was added. The mixture was incubated on ice with periodic stirring for 10 min. The total volume was brought to 2.5 ml by adding PBS (pH ϭ 7.4). After radioiodination, the coupled MAb was separated from free 125 I or 131 I by gel filtration on a Sephadex PD-10 column (Pharmacia Biotech, Piscataway, NJ). The column was equilibrated with PBS containing 1% BSA and was eluted with the same buffer. Two fractions of 2.5 ml were collected, the second of which contained the radiolabeled antibody. Absence of free 125 I or 131 I was ensured by extensive dialysis of the protein-containing fraction. Less than 1% of the activity of the protein fraction was recovered from the dialysis fluid. Labeled MAbs were stored at 4°C.
In anesthetized animals, the left jugular vein and left carotid artery were cannulated using polyethylene tubing (PE-50). To induce intestinal ischemia, the superior mesenteric artery was occluded using 0.80-mm vinyl tubing. MAbs were injected as a single bolus into the jugular vein catheter and allowed to circulate for 5 min. Each bolus contained a mixture of a binding 125 I (P-selectin-binding, 10 g)-labeled MAb and a nonbinding (irrelevant) 131 I-labeled MAb (P23, 1 g). Radiolabeled MAbs were allowed to circulate for 5 min to maximally bind to their ligands. Then a 0.5-ml blood sample was taken from the carotid artery catheter. The rats then underwent an isovolemic blood exchange using bicarbonatebuffered saline (BBS, pH 7.4). BBS was administered via the jugular catheter with simultaneous blood withdrawal from the carotid artery catheter. This was followed by perfusion of 60 ml of BBS through the carotid catheter after severing of the inferior vena cava at the thoracic level. The small intestine was harvested, weighed, and placed in a gamma-scintillation counter for radioactivity measurement.
The method for calculating P-selectin expression has been previously described (9, 27) . In brief, the 125 I (binding MAb) and the 131 I (nonbinding MAb) activities in small intestine and in 100-l samples of cell-free plasma were counted in a 14800 Wizard 3 gamma counter (Wallace, Turku, Finland) with automatic correction for background activity and spillover. A 3-l aliquot of the radiolabeled MAb mixture was assayed to determine total injected activity of each labeled MAb. The activities remaining in the tube used to mix the MAbs and the syringe used to inject the mixture were subtracted from the total injected activity. The accumulated activity of each MAb in an organ was expressed as the percentage of the injected activity per gram of tissue. This value, expressed as percent injected dose per gram of tissue, was converted to nanograms MAb per gram of tissue by multiplying the above value by the total injected binding MAb. Previous studies have shown that the binding MAbs retain their functional activity after radioiodination, as evidenced by a similar effectiveness of labeled and unlabeled MAbs to block leukocyte adherence in rat mesenteric venules (27) . In addition, we have shown that constitutive and endotoxin-induced expression of P-selectin is not detectable in the small intestine and other organs of mice that are genetically deficient in P-selectin (9) .
Tissue MPO Activity MPO activity was measured using the O-dianisidine MPO (OD-MPO) assay. Tissue samples from the distal small bowel were taken at the end of each experiment, placed in small test tubes, rinsed, blotted dry, and stored at Ϫ70°C until being thawed for MPO determination using the methods described below. Briefly, tissue samples were homogenized (10% wt/vol, 0.1 g/1 ml) in 0.5% fresh hexadecyltrimethylammonium bromide (HETAB) prepared by dissolving the HETAB in 50 mM Kpi (pH 6.0). Samples were then sonicated for 10 s, three times each (amplitude 30), and then transferred to 2-ml Eppendorf tubes. The samples were then centrifuged at 12,000 rpm for 10 min at 4°C. In disposable cuvettes, 2,900 l of 50 mM Kpi, pH 6.0, were added, one cuvette per sample. Thirty microliters of 20 mg/ml OD dihydrochloride and 30 l of 20 mM hydrogen peroxide were then added to the cuvettes, and the reaction was started by adding 100 l of the sample supernatant and run for 5 min at room temperature. The reaction was stopped using 30 l of a 30% sodium azide solution, and the absorbance of the sample reaction was read at 460 nm. After the absorbance of a blank was subtracted, the MPO activity was expressed as the amount of enzyme necessary to produce a change in absorbance of 1.0 per minute and per gram of wet weight of tissue.
Intravital Videomicroscopy
Intravital videomicroscopy was employed to monitor and quantify leukocyte-endothelial cell interactions of rat mesenteric venules. Anesthetized rats were placed in a supine position on an adjustable acrylic microscope stage, and the mesentery was prepared for microscopic observation, as described previously (25) . Briefly, the mesentery was draped over a nonfluorescent coverslip that allowed for observation of a 2-cm 2 segment of tissue. The exposed bowel wall was covered with Saran wrap (Dow Chemical), then the mesentery was superfused with BBS (37°C, pH 7.4) that was bubbled with a mixture of 5% CO2 and 95% N2. During each experiment, mean arterial pressure was monitored using a carotid catheter and a BP-1 pressure monitor (World Precision Instruments, Sarasota, FL).
An inverted microscope (Nikon, Tokyo, Japan) with a ϫ20 objective lens was used to observe the mesenteric microcirculation. The mesentery was transilluminated with a 12 V, 100 W direct current-stabilized light source. A video camera (CCD Iris, Sony, Tokyo, Japan) mounted on the microscope projected the image onto a color monitor (PVM-2030, Sony), and the images were recorded using a video cassette recorder (Mitsubishi HS-065). A video time-date generator (WJ810, Panasonic) projected the time, date, and stopwatch function onto the monitor.
Single unbranched venules with diameters ranging between 25 and 40 m and lengths Ͼ150 m were selected for study. Venular diameter (Dv) was measured either on-or off-line using a video caliper (Microcirculation Research Institute, Texas A&M University, College Station, TX). Red blood cell centerline velocity (Vmean) was measured in venules using an optical Doppler velocimeter (Microcirculation Research Institute). The velocimeter was calibrated against a rotating glass disc coated with red blood cells. Venular blood flow was calculated from the product of mean red blood cell velocity [Vmean ϭ centerline velocity/1.6] and microvascular cross-sectional area, assuming cylindrical geometry. Wall shear rate (°) was calculated based on the Newtonian definition:°ϭ 8(Vmean/D).
The number of adherent leukocytes was determined offline during playback of videotape images. A leukocyte was considered to be adherent to venular endothelium if it remained stationary for a period Ն30 s. Adherent cells were expressed as the number per 100-m length of venule. The number of emigrated leukocytes was also determined off-line during playback of videotaped images. Any interstitial leukocytes present in the mesentery at the onset of the experiment were subtracted from the total number of leukocytes that accumulated during the course of the experiment. Preparations with more than eight emigrated leukocytes per field of view under control (preischemic) conditions were not included in the study. Leukocyte emigration was expressed as the number per field of view surrounding the venule.
Experimental Protocols
In one series of experiments, we examined the changes in P-selectin and MPO activity (an index of neutrophil infiltration) in the small intestine after occlusion of the superior mesenteric artery for 45 min followed by 5 h of reperfusion. These measurements were obtained (at 5 h of reperfusion) in untreated (control) rats and in rats pretreated with either 1) antiplatelet serum (APS, 0.5 mg/kg) for reduction of the blood platelet count by Ͼ90% (n ϭ 5), 2) a blocking dose of the P-selectin MAb RMP-1 (2 mg/kg; n ϭ 8), 3) a blocking dose of the GPIIb/IIIa MAb 7E3 (0.5 mg/kg; n ϭ 5) or its F(abЈ)2 counterpart m7E3 F(abЈ)2 (0.5 mg/kg, n ϭ 5), 4) the RGD peptide GRGDSP (10 mg/kg, n ϭ 7), or 5) a blocking dose of an anti-fibrinogen MAb (17 mg/kg). The APS was administered 24 h before the experiment, whereas the blocking MAbs (anti-P-selectin and anti-GPIIb/IIIa) were administered 5 min before the induction of intestinal ischemia.
In a separate series of experiments, we examined the influence of different antiplatelet interventions on the enhanced leukocyte adherence and emigration elicited in mesenteric venules after 45 min of ischemia followed by 1 h of reperfusion. The following experimental groups were studied: 1) untreated (control) rats exposed to intestinal I/R (n ϭ 6), 2) intestinal I/R plus pretreatment with the GPIIb/IIIa MAb (7E3, 0.5 mg/kg; n ϭ 5), 3) intestinal I/R plus pretreatment with APS (n ϭ 9, as described above), 4) intestinal plus pretreatment with the anti-P-selectin MAb (n ϭ 5, as described above), 5) intestinal I/R plus pretreatment with an anti-fibrinogen MAb (17 mg/kg; n ϭ 6), and 6) intestinal I/R plus pretreatment with RGD peptide (10 mg/kg; n ϭ 5). The number of adherent and emigrated leukocytes was determined before the ischemic insult, 5 min after release of the superior mesenteric artery occlusion, and in the last 5 min of the 1-h reperfusion period.
Statistics
The data were analyzed using a one-way ANOVA with Scheffé's (post hoc) test (StatView 4.02 for Macintosh computers). All values are reported as means Ϯ SE. Statistical significance was set at P Ͻ 0.05. Figure 1 summarizes the results obtained from experiments employing the dual radiolabeled MAb technique to quantify P-selectin expression in rat intestine exposed to 45 min ischemia and 5 h reperfusion. Compared with sham (control) experiments, P-selectin expression was increased 45.3-fold after I/R. This profound I/R-induced increase in P-selectin expression was significantly blunted (13.6-fold increase) in rats rendered thrombocytopenic by prior treatment with APS. Similar attenuation of I/Rinduced P-selectin expression was noted in rats pretreated with either the parent GPIIb/IIIa MAb 7E3 (9.8-fold increase) or its F(abЈ) 2 fragment (9.0-fold increase). Treatment with the RGD peptide GRGDSP (13.7-fold increase) or the anti-fibrinogen MAb (16.4-fold increase) also led to attenuation of I/R-induced Pselectin expression. These findings indicate that platelets (and possibly P/E cell adhesion) account for a large proportion of the P-selectin expression that is observed in the postischemic intestinal microvasculature. Figure 2 presents the changes in intestinal MPO activity (an index of neutrophil accumulation) that were elicited by I/R. Compared with sham controls, I/R resulted in a 17.5-fold increase in tissue MPO activity. This I/R-induced recruitment of neutrophils was significantly blunted in thrombocytopenic animals (8.2-fold) and in rats pretreated with MAb 7E3 (3.5-fold) or its F(abЈ) 2 fragment (8.5-fold). Similarly, animals pretreated with the RGD peptide (8.8-fold) or anti-fibrinogen MAb (6.1-fold) showed a marked attenuation of the MPO response to I/R . The P-selectinblocking MAb, RMP-1, produced a similar attenuation (4.6-fold) of I/R-induced neutrophil accumulation. These results suggest that platelet-associated P-selectin plays an important role in mediating the recruitment of neutrophils into the postischemic small intestine. Fig. 1 . Effects of antiplatelet serum (APS), a GPIIb/IIIa monoclonal antibody (MAb; c7E3 IgG) and its F(abЈ)2 fragment m7E3 F(abЈ)2, an ArgGly-Asp (RGD) peptide, and anti-fibrinogen MAb on ischemia/reperfusion (I/R)-induced P-selectin expression in rat small intestine. *P Ͻ 0.05 relative to the control value; #P Ͻ 0.05 relative to I/R alone. Fig. 2 . Effects of APS, an anti-P-selectin MAb, a GPIIb/IIIa MAb (c7E3 IgG), and its F(abЈ)2 fragment m7E3 F(abЈ)2, an RGD peptide, and anti-fibrinogen MAb on I/R-induced neutrophil accumulation (myeloperoxidase activity) in rat small intestine. *P Ͻ 0.05 relative to the control value; #P Ͻ 0.05 relative to I/R alone.
RESULTS
Whole Organ Experiments P-selectin expression after I/R.
Neutrophil accumulation after I/R.
Intravital Microscopy Experiments
Leukocyte adherence in postischemic venules. Fortyfive minutes of superior mesenteric artery occlusion followed by 1 h of reperfusion elicits about a sevenfold increase in the number of adherent leukocytes per 150-m length of mesenteric venule (Fig. 3) . Whereas this response to I/R was unchanged in thrombocytopenic animals, all other platelet-directed interventions, including MAbs directed against either GPIIb/IIIa, Pselectin, or fibrinogen, and an RGD peptide, effectively attenuated the I/R-induced recruitment of adherent leukocytes. These findings largely (except the APS data) support the view that platelets may contribute in some manner to the recruitment of adherent leukocytes in the postischemic microvasculature.
Leukocyte emigration in postischemic venules. Figure  4 summarizes the changes in leukocyte emigration that are elicited in postischemic mesenteric venules of control and treated rats. Compared with sham (control) rats, I/R elicited a 4.5-fold increase in the number of emigrated leukocytes surrounding mesenteric venules. This I/R-induced transendothelial migration of leukocytes was largely abolished by APS and all other platelet-directed interventions. These data suggest that platelets play an important role in modulating the leukocyte emigration that is elicited by I/R in the mesenteric microcirculation.
DISCUSSION
There is a large body of evidence in the literature that supports a role for platelets in the pathogenesis of I/R injury. For example, I/R-induced liver injury, as assessed by release of transaminases (e.g., alanine aminotransferase) into the circulation, is aggravated by the presence of platelets (7) . Platelets have also been implicated in the pathogenesis of I/R injury in the heart. Interventions directed toward either depleting platelets (10) or preventing P/E adhesion (3) have proven to be effective in reducing the tissue necrosis as well as the leukocyte accumulation induced by myocar- Fig. 3 . Leukocyte adherence in rat mesenteric venules after I/R. Some animals were treated with either APS, RGD peptide, or a MAb antibody against either GPIIb/IIa, P-selectin, or fibrinogen. *P Ͻ 0.05 relative to the control value; #P Ͻ 0.05 relative to I/R alone. Fig. 4 . Leukocyte emigration in rat mesenteric venules after I/R. Some animals were treated with either APS, RGD peptide, or a MAb against either GPIIb/IIIa, Pselectin, or fibrinogen. *P Ͻ 0.05 relative to the control value; #P Ͻ 0.05 relative to I/R alone. dial I/R, suggesting that platelets may also modulate the recruitment of leukocytes into postischemic tissues. Platelets are also known to accumulate in the microvasculature of postischemic tissues (16) . This has been demonstrated using biopsy specimens of transplanted human kidneys (16) as well as intravital microscopic observations of postischemic tissues in the splanchnic circulation (23) . Immunofluorescent doublestaining procedures applied to kidney biopsy specimens have revealed that the accompanying increase in P-selectin expression resulted from platelet deposition and not from endothelial activation per se (16) . It has also been reported that platelets accumulate within the liver microvasculature and adhere to endothelial cells within a few minutes after reperfusion of livers cold preserved for 45 min (7). Similar findings have come from studies focusing on the interactions of fluorescently labeled platelets with endothelial cells in intestinal venules after I/R (23). The latter experiments revealed that platelets, like leukocytes, roll along and firmly adhere to venular endothelium within 5 min after the onset of reperfusion, indicating that platelets are among the first cells recruited into the postischemic vasculature. Furthermore, the density (cells per unit vessel area) of recruited platelets in postischemic venules can exceed the density of adherent leukocytes by an order of magnitude. In a subsequent series of experiments, the same investigators (24) demonstrated that 1) fibrinogen is deposited on postischemic venular endothelium via an intercellular adhesion molecule (ICAM)-1-dependent mechanism and 2) treatment with either anti-fibrinogen and anti-ICAM-1 MAbs, a GPIIb/IIIa antagonist, or RGD peptide significantly attenuate I/R-induced P/E cell adhesion. On the basis of these observations, it was proposed that I/R elicits fibrinogen deposition (binding) to constitutively expressed ICAM-1 on venular endothelial cells, with the bound fibrinogen serving as a ligand for GPIIb/IIIa expressed on activated platelets (24) . These activated and adherent platelets also express P-selectin, onto which leukocytes may roll and adhere in the vasculature (15) .
Because it has recently been suggested that platelet accumulation in postischemic tissues may account for the elevated P-selectin expression detected therein (12) and because P-selectin-dependent leukocyte-endothelial cell adhesion has been implicated in the pathogenesis of I/R injury in a number of tissues (4), we chose to address two questions that remained unanswered in the literature: 1) do platelets contribute to the increased P-selectin expression that is detected in postischemic tissue and 2) do platelets contribute to I/Rinduced, P-selectin-dependent leukocyte recruitment? The results of our study clearly support a role for platelets in the increased P-selectin expression that is elicited in the small bowel by I/R. Furthermore, our findings suggest that platelet-associated P-selectin contributes to the accumulation of leukocytes in postischemic intestine.
The contribution of platelets to I/R-induced P-selectin expression was addressed using quantitative measurements of adhesion molecule expression in untreated rats and in rats receiving either APS or reagents known to interfere with I/R-induced P/E cell adhesion. Previously published intravital microscopic studies of the intestinal vasculature have demonstrated that GPIIb/IIIa is a critical determinant of the P/E cell adhesion that is elicited by I/R (24) . This adhesion molecule can also mediate platelet aggregation and platelet-leukocyte adhesion (31) . Our finding that profound depletion of circulating platelets with APS or inhibition of P/E cell adhesion and/or homotypic aggregation with a MAb directed against either GPIIb/ IIIa or fibrinogen greatly attenuates I/R-induced Pselectin expression supports a role for platelets in this response. It should be noted that whereas APS exerts this dramatic effect on I/R-induced P-selectin expression, thrombocytopenic rats do not exhibit an altered P-selectin expression response to endotoxin challenge (5), indicating that the contribution of platelets to elevated "vascular" expression of P-selectin may be unique to I/R.
A functional consequence of the attenuated I/R-induced P-selectin expression induced by the plateletdirected interventions is a blunted leukocyte-recruitment response, as reflected in the attenuated MPO responses to I/R. In view of the inhibitory actions of these same reagents on P-selectin expression, it appears likely that the blunted MPO responses are causally linked to the corresponding reductions in P-selectin expression. This possibility is supported by our observation that blocking doses of the P-selectin-specific MAb was also quite effective in blunting the leukocyte recruitment elicited by intestinal I/R. Similar to the other reagents tested in the MPO experiments, the GPIIb/IIIa MAb appears to produce a dramatic attenuation. Whereas this response may reflect the actions of this MAb on GPIIb/IIIa receptors on platelets, it may also result from the well-documented effects of GPIIb/ IIIa MAbs (including 7E3) on the leukocyte adhesion receptor CD11b/CD18 (Mac-1, ␣M␤ ␤2) (6, 30) , which has also been implicated in the leukocyte recruitment associated with intestinal I/R (19) .
The platelet-dependent rise in intestinal MPO after I/R may reflect an increase in the number of adherent and/or emigrated neutrophils in the intestinal vasculature. To address this issue, we monitored leukocyte adhesion and emigration in postischemic mesenteric venules of untreated rats and animals subjected to different antiplatelet interventions. Given the uncertainties about the specificity of the GPIIb/IIIa MAb, we also tested other agents, which have recently been shown to interfere with platelet-leukocyte adhesion in postischemic intestinal venules (24), i.e., an anti-fibrinogen MAb and the RGD peptide GRGDSP. The results obtained from the intravital microscopy experiments revealed that virtually all of the antiplatelet interventions tested attenuated both the leukocyte adherence and emigration responses to I/R, which is consistent with the aforementioned MPO responses to intestinal I/R. A notable exception to this pattern of protection was the absence of an effect of APS on leukocyte adherence, whereas it greatly attenuated the leukocyte emigration response to I/R. This observation suggests that the attenuated MPO response observed in the postischemic intestine of thrombocytopenic animals largely results from an attenuated transendothelial migration of leukocytes rather than diminished leukocyte-endothelial cell adhesion.
Platelets could contribute to the P-selectin-dependent recruitment of leukocytes after I/R in different ways. I/R is known to promote P/E cell adhesion in the intestinal vasculature via previously described mechanisms that involve GPIIb/IIIa, fibrinogen, and RGD (24) . These adherent platelets could initiate P-selectindependent leukocyte recruitment either by creating a P-selectin-rich platform on the surface of endothelial cells onto which leukocytes can roll and adhere or by releasing mediators (e.g., histamine, thrombin) that induce endothelial cells to express P-selectin (14, 17) and cause endothelial cell retraction (1, 28) , the latter of which would facilitate transendothelial leukocyte migration. Our results do not allow us to distinguish between these two (and other) possibilities, nor do they allow for clear delineation of the contributions of platelet-vs. endothelial cell-associated P-selectin in mediating I/R-induced leukocyte recruitment. We cannot exclude the possibility that blockade of platelet adhesion attenuates leukocyte adhesion via mechanisms that are independent of P-selectin expression, because it has been shown that activated platelets induce chemokine secretion and increase surface expression of ICAM-1 on cultured endothelial cells (9) . The findings do suggest, however, that platelets may play a major role in I/R-induced P-selectin expression and in the resultant leukocyte recruitment. The data also justify further exploration into the mechanisms employed by platelets to recruit leukocytes.
